Overview
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Eligibility
Inclusion Criteria:
- ≥18 years of age
- Willing to participate in the research
- Able to provide informed consent
- Must be diagnosed with cancer
Exclusion Criteria:
- Not willing or able to have additional blood samples collected